Cargando…
Comparative proteogenomic characterization of glioblastoma
AIM: Glioblastoma multiforme (GBM) carries a dismal prognosis. Integrated proteogenomic analysis was performed to understand GBM pathophysiology. PATIENTS & METHODS: 17 patient samples were analyzed for driver mutations, oncogenes, major pathway alterations and molecular changes at gene and prot...
Autores principales: | Asif, Samia, Fatima, Rawish, Krc, Rebecca, Bennett, Joseph, Raza, Shahzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713026/ https://www.ncbi.nlm.nih.gov/pubmed/31290679 http://dx.doi.org/10.2217/cns-2019-0003 |
Ejemplares similares
-
Proteogenomic characterization and integrative analysis of glioblastoma multiforme
por: Song, Ying-Chun, et al.
Publicado: (2017) -
Proteogenomic characterization of ferroptosis regulators reveals therapeutic potential in glioblastoma
por: Wang, Xinzhuang, et al.
Publicado: (2023) -
Proteogenomic characterization of cholangiocarcinoma
por: Deng, Mengjie, et al.
Publicado: (2023) -
Integrated proteogenomic characterization of urothelial carcinoma of the bladder
por: Xu, Ning, et al.
Publicado: (2022) -
Integrated proteogenomic characterization of medullary thyroid carcinoma
por: Shi, Xiao, et al.
Publicado: (2022)